[HTML][HTML] Novel therapeutics for treating organophosphate-induced status epilepticus co-morbidities, based on changes in calcium homeostasis

LS Deshpande, RJ DeLorenzo - Neurobiology of disease, 2020 - Elsevier
Organophosphate (OP) chemicals include pesticides such as parathion, and nerve gases
such as sarin and soman and are considered major chemical threat agents. Acute OP …

HI-6-loaded PEGylated liposomes: an on-site first-aid strategy for acute organophosphorus agent poisoning

L Shen, Y Zhang, Q Cai, J Yang, Y Wang, D Quan - Drug Delivery, 2023 - Taylor & Francis
Organophosphorus agents, also known as nerve agents, are very dangerous chemicals that
were used as chemical warfare agents. HI-6 is one of the most promising reactivators which …

Screening for efficacious anticonvulsants and neuroprotectants in delayed treatment models of organophosphate-induced status epilepticus

BS Barker, J Spampanato, HS McCarren, M Smolik… - Neuroscience, 2020 - Elsevier
Organophosphorus (OP) compounds are deadly chemicals that exert their intoxicating
effects through the irreversible inhibition of acetylcholinesterase (AChE). In addition to an …

Combination of acetylcholinesterase inhibitors and NMDA receptor antagonists increases survival rate in soman-poisoned mice

J Kassa, J Zdarova Karasova - Toxicology Mechanisms and …, 2023 - Taylor & Francis
Organophosphorus nerve agents pose a global threat to both military personnel and civilian
population, because of their high acute toxicity and insufficient medical countermeasures …

The Kv7 modulator, retigabine, is an efficacious antiseizure drug for delayed treatment of organophosphate-induced status epilepticus

BS Barker, J Spampanato, HS McCarren, K Berger… - Neuroscience, 2021 - Elsevier
Benzodiazepines are the primary treatment option for organophosphate (OP)-induced status
epilepticus (SE), but these antiseizure drugs (ASDs) lose efficacy as treatment is delayed. In …

A rapid in vitro assay for evaluating the effects of acetylcholinesterase inhibitors and reactivators in the rat basolateral amygdala

JS Thinschmidt, SW Harden, MA King… - Frontiers in Cellular …, 2022 - frontiersin.org
We established a novel brain slice assay to test the ability of acetylcholinesterase (AChE)
reactivators to prevent ACh-induced M1 muscarinic acetylcholine receptor (mAChR) …

Effects of memantine and its metabolite Mrz 2/373 on soman-induced inhibition of acetylcholinesterase in vitro

MP Stojiljković, R Škrbić, M Jokanović… - Chemico-Biological …, 2021 - Elsevier
Memantine is the non-competitive N-methyl-d-aspartate (NMDA) receptor antagonist, used
in the treatment of Alzheimer's disease. It is also known that memantine pretreatment …

[PDF][PDF] Pharmacological treatment of amyotrophic lateral sclerosis: Potential leads from preclinical epilepsy and nerve agent research

T Myhrer - researchgate.net
Amyotrophic lateral sclerosis (ALS) is a degenerative disorder affecting motor neurons in the
neocortex, brainstem, and spinal cord. About 10% of ALS cases can be related to genetic …

Nerve Agent–Induced Seizures and Status Epilepticus: Neuroprotective Strategies

F Doreu, K Thibault, N Dupuis - Chemical Warfare Agents, 2019 - taylorfrancis.com
The propensity to induce central effects depends on the Organophosphorus pesticide and its
ability to induce them before life-threatening peripheral effects start, especially respiratory …